纖維介素蛋白(FGL2)多克隆抗體
Polyclonal Antibody to Fibrinogen Like Protein 2 (FGL2)
T49; PT49; Fibroleukin
- 編號UPAA512Hu01
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPA512Hu01-纖維介素蛋白(FGL2)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度0.5mg/mL
- 且適物種Mus musculus (Mouse,小鼠)
- 應(yīng)用WB; IHC
如果抗體需用于流式細胞術(shù),請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 284 ¥ 664 ¥ 948 ¥ 2370 ¥ 9480
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對FGL2的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別FGL2。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
URPA512Hu01 | 纖維介素蛋白(FGL2)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
UPAA512Hu01 | 纖維介素蛋白(FGL2)多克隆抗體 | WB; IHC |
UMAA512Hu22 | 纖維介素蛋白(FGL2)單克隆抗體 | WB; IHC; ICC; IP. |
USEA512Hu | 纖維介素蛋白(FGL2)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
ULMA512Hu | 纖維介素蛋白(FGL2)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Gut. | Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3 [PubMed: 22637698] |
Hepatogastroenterology. | Plasma fibrinogen-like protein 2 levels in patients with non-alcoholic fatty liver disease. [PubMed: 22024080] |
PLoS Pathogens | Programmed Death (PD)-1-Deficient Mice Are Extremely Sensitive to Murine Hepatitis Virus Strain-3 (MHV-3) Infection [PubMed: PMC3131267] |
Immunology letters | Tumor necrosis factor α (TNF-α) receptor-I is required for TNF-α-mediated fulminant virus hepatitis caused by murine hepatitis virus strain-3 infection. [Pubmed: 24286726 ] |
Immunol Lett. | Tumor necrosis factor α (TNF-α) receptor-I is required for TNF-α-mediated fulminant virus hepatitis caused by murine hepatitis virus strain-3 infection [Pubmed:24286726] |
NATURE COMMUNICATIONS | VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism [pubmed:29109438] |
Cancer?Medicine | Soluble fibrinogen‐like protein 2 ameliorates acute rejection of liver transplantation in rat via inducing Kupffer cells M2 polarization [Pubmed:29749104] |
BMC?Infectious?Diseases | Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases [Pubmed: 30419833] |
Int J Gynaecol Obstet | Tandem mass tag?\based quantitative proteomic profiling of the serum of patients with abnormal uterine bleeding associated with copper intrauterine device [33354778] |